RMR Wealth Builders’s Corbus Pharmaceuticals CRBP Stock Holding History

RMR Wealth Builders’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7	Closed	-$2K	–	275
2020 Q2	$2K	Buy	+7	New	+$1.42K	﹤0.01%	408

Other funds holding CRBP

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

RMR Wealth Builders's CRBP Position: Q3 2020 in Review

RMR Wealth Builders sold out of Corbus Pharmaceuticals (CRBP) in Q3 2020, closing a stake of 7 shares — an estimated $2K sold.

RMR Wealth Builders first reported a position in CRBP in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 122 funds tracked by Wall St. Rank hold CRBP as of Q3 2020.

RMR Wealth Builders reported no remaining Corbus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
RMR Wealth Builders sold 7 Corbus Pharmaceuticals shares in Q3 2020, an estimated $2K.
RMR Wealth Builders first reported a position in Corbus Pharmaceuticals in Q2 2020 and held it in 1 quarter.
RMR Wealth Builders's Corbus Pharmaceuticals position peaked at $2K in Q2 2020.
122 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2020.

Based on RMR Wealth Builders's 13F filing for Q3 2020, filed 13 Nov 2020.